Human IFN-γ ELISA antibody pair - 10-plate

SKU
CT740-10
Validated ELISA antibody pair with standard and conjugate; reagents available separately (960 determinations).
Format
10-plate
Price
€ 625
Documentation
Data sheet
Manual
SDS
Reactivity
Human
Category
ELISA
Analyte
IFN-γ
Description
Our ELISA antibody pairs are extensively validated for high assay performance using the same reagents and materials included in U-CyTech ELISA kits. These antibody pairs are optimized to ensure reliable, sensitive, and reproducible results in a wide range of ELISA applications.
The ELISA antibody pairs are available in convenient 10- or 20-plate formats, providing 960 or 1920 determinations, respectively. Each set is supplied with either 5 or 10 vials of standards and 2 or 4 vials of Streptavidin-HRP conjugate, offering flexibility for different experimental needs and throughput requirements.
Designed for ease of use and consistent performance, these ELISA reagents support accurate quantification in immunoassays. Additional ELISA plates and reagents can be purchased separately, allowing customization of your ELISA workflow.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Gene ID
3458

References

Authors, et al. Title Journal Year Volume Pages
Ying-Mei Tang Kinetics of phytohemaglutinin-induced IFN-gamma and TNF-alpha expression in peripheral blood mononuclear cells from patients with chronic hepatitis B after liver transplantation World J Gastroenterol 2005 11 4574-8
R van der Linden Virus specific immune responses after human neoadjuvant adenovirus-mediated suicide gene therapy for prostate cancer Eur Urol 2005 48 153-61
Jeroen Stoop Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection Hepatology 2005 41 771-8
Mary Morgan Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans Hum Immunol 2005 66 13-20
S Arend Pneumonia caused by Mycobacterium kansasii in a series of patients without recognised immune defect Clin Microbiol Infect 2004 10 738-48
Gamze Piskin T cells in psoriatic lesional skin that survive conventional therapy with NB-UVB radiation display reduced IFN-gamma expression Arch Dermatol Res 2004 295 509-16
Frank Verreck Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria Proc Natl Acad Sci U S A 2004 101 4560-5
A Geluk Immunological crossreactivity of the Mycobacterium leprae CFP-10 with its homologue in Mycobacterium tuberculosis Scand J Immunol 2004 59 66-70
Marieke Hoeve IL-12 receptor deficiency revisited: IL-23-mediated signaling is also impaired in human genetic IL-12 receptor beta1 deficiency Eur J Immunol 2003 33 3393-7
Padraic Fallon Juvenile rhesus monkeys have lower type 2 cytokine responses than adults after primary infection with Schistosoma mansoni J Infect Dis 2003 187 939-45